FYERS
Home
/
Stocks
/
Profit Loss
/
Biocon Profit & Loss

Biocon Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018Mar 2018Dec 2017Sep 2017Jun 2017Mar 2017Dec 2016Sep 2016Jun 2016Mar 2016Dec 2015Sep 2015Jun 2015Mar 2015Dec 2014Sep 2014Jun 2014Mar 2014Dec 2013Sep 2013Jun 2013Mar 2013Dec 2012Sep 2012
₹4336 Cr₹4517 Cr₹4173 Cr₹4296 Cr₹3942 Cr₹4417 Cr₹3821 Cr₹3590 Cr₹3433 Cr₹3917 Cr₹3954 Cr₹3462 Cr₹3423 Cr₹3774 Cr₹2941 Cr₹2320 Cr₹2140 Cr₹2409 Cr₹2174 Cr₹1840 Cr₹1761 Cr₹1842 Cr₹1857 Cr₹1750 Cr₹1694 Cr₹1558 Cr₹1717 Cr₹1567 Cr₹1459 Cr₹1529 Cr₹1541 Cr₹1321 Cr₹1124 Cr₹1170 Cr₹1058 Cr₹969 Cr₹934 Cr₹931 Cr₹1044 Cr₹954 Cr₹992 Cr₹957 Cr₹800 Cr₹789 Cr₹814 Cr₹838 Cr₹769 Cr₹758 Cr₹725 Cr₹729 Cr₹707 Cr₹741 Cr₹701 Cr₹637 Cr₹643 Cr₹629 Cr
₹55 Cr₹53 Cr₹117 Cr₹93 Cr₹80 Cr₹37 Cr₹35 Cr₹33 Cr₹1135 Cr₹49 Cr₹566 Cr₹158 Cr₹94 Cr₹155 Cr₹79 Cr₹65 Cr₹78 Cr₹67 Cr₹48 Cr₹105 Cr₹47 Cr₹205 Cr₹28 Cr₹16 Cr₹18 Cr₹63 Cr₹36 Cr₹38 Cr₹24 Cr₹28 Cr₹26 Cr₹54 Cr₹69 Cr₹68 Cr₹34 Cr₹51 Cr₹54 Cr₹43 Cr₹47 Cr₹38 Cr₹41 Cr₹16 Cr₹22 Cr₹23 Cr₹20 Cr₹17 Cr₹10 Cr₹15 Cr₹17 Cr₹17 Cr₹12 Cr₹12 Cr₹22 Cr₹12 Cr₹17 Cr₹13 Cr
₹4391 Cr₹4569 Cr₹4290 Cr₹4389 Cr₹4022 Cr₹4454 Cr₹3856 Cr₹3623 Cr₹4567 Cr₹3966 Cr₹4519 Cr₹3620 Cr₹3516 Cr₹3929 Cr₹3020 Cr₹2384 Cr₹2217 Cr₹2476 Cr₹2223 Cr₹1945 Cr₹1808 Cr₹2048 Cr₹1885 Cr₹1765 Cr₹1712 Cr₹1621 Cr₹1753 Cr₹1606 Cr₹1483 Cr₹1557 Cr₹1566 Cr₹1375 Cr₹1193 Cr₹1237 Cr₹1092 Cr₹1019 Cr₹988 Cr₹974 Cr₹1092 Cr₹993 Cr₹1033 Cr₹973 Cr₹822 Cr₹811 Cr₹834 Cr₹855 Cr₹779 Cr₹773 Cr₹742 Cr₹746 Cr₹720 Cr₹753 Cr₹723 Cr₹649 Cr₹660 Cr₹642 Cr
₹4036 Cr₹4010 Cr₹3855 Cr₹3933 Cr₹3631 Cr₹3775 Cr₹3495 Cr₹3325 Cr₹3218 Cr₹3408 Cr₹3441 Cr₹3110 Cr₹3066 Cr₹3140 Cr₹2598 Cr₹2080 Cr₹1958 Cr₹2029 Cr₹1892 Cr₹1596 Cr₹1566 Cr₹1591 Cr₹1644 Cr₹1536 Cr₹1447 Cr₹1391 Cr₹1417 Cr₹1296 Cr₹1146 Cr₹1246 Cr₹1277 Cr₹1094 Cr₹985 Cr₹1032 Cr₹934 Cr₹880 Cr₹840 Cr₹816 Cr₹839 Cr₹782 Cr₹795 Cr₹817 Cr₹679 Cr₹681 Cr₹665 Cr₹711 Cr₹666 Cr₹639 Cr₹603 Cr₹607 Cr₹583 Cr₹615 Cr₹597 Cr₹571 Cr₹539 Cr₹521 Cr
₹902 Cr₹1073 Cr₹951 Cr₹928 Cr₹846 Cr₹1115 Cr₹787 Cr₹718 Cr₹1755 Cr₹965 Cr₹1492 Cr₹900 Cr₹808 Cr₹1152 Cr₹723 Cr₹535 Cr₹477 Cr₹659 Cr₹537 Cr₹551 Cr₹437 Cr₹641 Cr₹428 Cr₹407 Cr₹432 Cr₹382 Cr₹480 Cr₹441 Cr₹462 Cr₹431 Cr₹406 Cr₹394 Cr₹307 Cr₹301 Cr₹256 Cr₹233 Cr₹246 Cr₹231 Cr₹324 Cr₹278 Cr₹304 Cr₹221 Cr₹206 Cr₹192 Cr₹228 Cr₹202 Cr₹170 Cr₹188 Cr₹191 Cr₹193 Cr₹188 Cr₹188 Cr₹175 Cr₹124 Cr₹167 Cr₹166 Cr
₹213 Cr₹232 Cr₹210 Cr₹272 Cr₹277 Cr₹212 Cr₹223 Cr₹226 Cr₹236 Cr₹227 Cr₹267 Cr₹248 Cr₹233 Cr₹249 Cr₹120 Cr₹30 Cr₹20 Cr₹11 Cr₹15 Cr₹23 Cr₹20 Cr₹34 Cr₹5 Cr₹7 Cr₹13 Cr₹17 Cr₹18 Cr₹14 Cr₹17 Cr₹16 Cr₹19 Cr₹19 Cr₹18 Cr₹17 Cr₹15 Cr₹14 Cr₹16 Cr₹5 Cr₹9 Cr₹7 Cr₹6 Cr₹21 Cr₹2 Cr₹3 Cr₹4 Cr₹0₹5 Cr₹5 Cr₹58 L₹73 L₹26 L₹34 L₹38 L₹95 L₹3 Cr₹1 Cr
₹128 Cr₹248 Cr-₹68 Cr₹171 Cr₹97 Cr₹487 Cr₹156 Cr₹98 Cr₹1146 Cr₹322 Cr₹832 Cr₹239 Cr₹217 Cr₹537 Cr₹30 Cr₹257 Cr₹240 Cr₹396 Cr₹316 Cr₹257 Cr₹222 Cr₹436 Cr₹237 Cr₹223 Cr₹252 Cr₹213 Cr₹318 Cr₹363 Cr₹321 Cr₹296 Cr₹277 Cr₹452 Cr₹190 Cr₹188 Cr₹144 Cr₹126 Cr₹131 Cr₹153 Cr₹244 Cr₹204 Cr₹232 Cr₹404 Cr₹141 Cr₹20 Cr₹165 Cr₹249 Cr₹109 Cr₹129 Cr₹138 Cr₹138 Cr₹137 Cr₹137 Cr₹126 Cr₹279 Cr₹118 Cr₹120 Cr
₹137 Cr₹199 Cr-₹52 Cr₹133 Cr₹89 Cr₹459 Cr₹81 Cr₹27 Cr₹862 Cr₹226 Cr₹777 Cr₹197 Cr₹182 Cr₹455 Cr₹35 Cr₹110 Cr₹210 Cr₹337 Cr₹267 Cr₹210 Cr₹165 Cr₹366 Cr₹188 Cr₹200 Cr₹171 Cr₹159 Cr₹234 Cr₹263 Cr₹236 Cr₹255 Cr₹231 Cr₹379 Cr₹138 Cr₹148 Cr₹107 Cr₹83 Cr₹94 Cr₹143 Cr₹190 Cr₹162 Cr₹177 Cr₹349 Cr₹119 Cr-₹8 Cr₹127 Cr₹217 Cr₹98 Cr₹107 Cr₹107 Cr₹119 Cr₹110 Cr₹105 Cr₹96 Cr₹251 Cr₹93 Cr₹90 Cr

Share Price Live Stats

Open (₹)354.00
Volume (₹)17.30 L
High (₹)356.35
Upper Circuit361.20
Low (₹)350.00
Lower Circuit340.20
Prev Close350.60
52W High (₹)447.15
Price352.00
52W Low (₹)337.70

Share Market Cap & Key Ratios Overview

M.Cap (₹)57243.00 Cr
Div. Yield (%)0.14
PE Ratio115.57
Debt to Equity0.44
Price to Book1.75
Book Value206.77
EPS (TTM)3.04
Face Value5.00
ROE (%)1.35

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
LAURUSLABSNSE
CIPLANSE
DRREDDYNSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
BIOCONNSE
LTP
1W Low
1W High
Market cap (₹)
1764+4 (0.23%)
1725.50
1778
4,19,620Cr
9030-310 (-3.32%)
8937.50
9431.50
2,39,714Cr
4584.1-72.8 (-1.56%)
4551.80
4682
1,74,741Cr
1140.2+22.7 (2.03%)
1107.30
1150.90
1,12,119Cr
2018.5-18.1 (-0.89%)
2007.80
2069.20
1,10,008Cr
1328+27 (2.08%)
1300.20
1336.40
1,06,061Cr
1218.8+21.8 (1.82%)
1196.90
1250.70
1,01,339Cr
2347.6-20.9 (-0.88%)
2317.50
2426.80
96,244Cr
1677.9-15.1 (-0.89%)
1647.10
1715
95,590Cr
1980.9+24.4 (1.25%)
1925.70
1990.90
89,391Cr
352+2.6 (0.74%)
342.15
356.35
57,243Cr
Empty box

No content available